This study is completed in the United States. It is testing safety and Tolerability for schizophrenia.
SchizophreniaDrugFrom 18 Years to 64 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Safety and Tolerability may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Safety and Tolerability, attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 21 sites
Birmingham Psychiatry Pharmaceutical
Birmingham, Alabama
Site status: Not listed — confirm with the team
Summit Research Group
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Comprehensive NeuroScience
Cerritos, California
Site status: Not listed — confirm with the team
Collaborative Neuro Science Network, Inc.
Garden Grove, California
Site status: Not listed — confirm with the team
Optimum Health Services
La Mesa, California
Site status: Not listed — confirm with the team
California Clinical Trials
San Diego, California
Site status: Not listed — confirm with the team
CA Neutopsychopharmacology Clinical Research Institute (CNRI)
San Diego, California
Site status: Not listed — confirm with the team
Pacific Clinical Research
Upland, California
Site status: Not listed — confirm with the team
Comprehensive NeuroScience, Inc
Washington D.C., District of Columbia
Site status: Not listed — confirm with the team
Segal Institute for Clinical Research
Fort Lauderdale, Florida
Site status: Not listed — confirm with the team
Segal Institute for Clinical Research
North Miami, Florida
Site status: Not listed — confirm with the team
University of South Florida, Department of Psychiatry and Behavioral Medicine
Tampa, Florida
Site status: Not listed — confirm with the team
Comprehensive Neuroscience, Inc.
Hoffman Estates, Illinois
Site status: Not listed — confirm with the team
Las Vegas
Las Vegas, Nevada
Site status: Not listed — confirm with the team
CNS Research Institute
Clementon, New Jersey
Site status: Not listed — confirm with the team
Quantum Clinical Services Group
Philadelphia, Pennsylvania
Site status: Not listed — confirm with the team
Community Clinical Research
Austin, Texas
Site status: Not listed — confirm with the team
Future Search Trials
Austin, Texas
Site status: Not listed — confirm with the team
Claghorn Lesem Research Clinic, Inc.
Bellaire, Texas
Site status: Not listed — confirm with the team
InSite Clinical Research
DeSoto, Texas
Site status: Not listed — confirm with the team
CBH Health, L.L.C - Dominion Hospital
Falls Church, Virginia
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00088621. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Lurasidone 80mg tablet. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 64 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
